| Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers (NCT02041416) | City of Hope Medical Center | 2013-05-15 |
| Phase II Maraviroc for GVHD Prevention (NCT01785810) | Abramson Cancer Center at Penn Medicine | 2013-02-01 |
| Evaluation of PET/MRI in Children With Cancer (NCT01839747) | Massachusetts General Hospital | 2012-10-31 |
| Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens (NCT01572181) | Nantes University Hospital | 2012-04-01 |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives (NCT01532635) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-03-01 |
| Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation (NCT01554254) | Tarix Pharmaceuticals | 2012-03-01 |
| Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer (NCT01324310) | Celgene | 2011-04-01 |
| Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow (NCT02049424) | Istituto Clinico Humanitas | 2011-03-01 |
| Influenza Vaccine Post Allogeneic Transplant (NCT01215981) | Masonic Cancer Center, University of Minnesota | 2010-09-01 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies (NCT01341301) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2010-05-01 |
| Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy (NCT00990587) | University Health Network, Toronto | 2009-10-01 |
| Outcomes of Critically Ill Patients With Hematologic Malignancies (NCT06410066) | Soroka University Medical Center | 2009-01-01 |
| A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (NCT00840190) | Piramal Enterprises Limited | 2008-12-01 |
| Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies (NCT00673114) | Joanne Kurtzberg, MD | 2007-08-01 |
| Voraxaze for Delayed Methotrexate Clearance (NCT00424645) | M.D. Anderson Cancer Center | 2007-01-01 |
| Genetics in the Progression of Nephropathies (NCT06416761) | Ospedale San Raffaele | 2006-05-19 |
| Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes (NCT00300001) | Community Cancer Care | 2006-03-01 |
| CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation (NCT00333190) | Dana-Farber Cancer Institute | 2005-09-01 |
| Fatigue in Emergency Center Patients (NCT00504985) | M.D. Anderson Cancer Center | 2005-08-01 |
| Mindfulness Meditation in Bone Marrow Transplantation (NCT00165282) | Emory University | 2005-04-01 |
| Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant (NCT00476177) | Dana-Farber Cancer Institute | 2003-07-01 |
| Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases (NCT00056966) | Baylor College of Medicine | 2002-11-01 |